ONCONASE for mesothelioma is a new drug for chemotherapy, that is in its' 3rd phase of clinical trials. The company that distributes the drug is called Alfacell, and their drug is actually named ranpirnase, slightly modified to better suit the requirements for mesothelioma chemotherapy treatment, attacking specific groups of cells and fighting tumor growth.
ONCONASE is a ribonuclease that inhibits cell growth and forces the initiation of programmed cellular death. That is exactly what a chemotherapy drug or treatment cycle is supposed to do, kill cancer cells and stop them from spreading.
The drugs' name derived from a combination of the words oncology ( tumor study) and ribonuclease. It is named that way to provide basic information about the content and the use it is intended for.
Mesothelioma ONCONASE trials
Patients that meet the requirement to perform phase 3 trials are split into two groups:
- 1st group receives a combination of doxorubicin and onconase for about 4 months, and the results are cataloged.
- 2nd group only receives doxorubicin, for about 4 months, once each three weeks. Patients and monitored and results are made public after thorough studying.
Onconase Phase 3 trials are final, and after the drug is thoroughly tested and examined it will be released as a chemotherapy treatment drug for mesothelioma. Speaking of doxorubicin, it will be used together with onconase because it has already been thoroughly tested and has proved to be effective against malignancies. Doctors hope that, if administered together, these two drugs will be effective enough to possibly cure mesothelioma cancer at a certain point.
Mainly, the drug will act similar to older drugs, that are in use for a lot of years, the difference is that ONCONASE can tell healthy cells apart from cancerous cells, and will only attack mesothelioma cancer cells. This is what doctors and physicians are actually testing, because they already know how effective it is.
ONCONASE clinical trials can be found in mesothelioma cancer centers, and information regarding these trials can be found in any specialized doctors' office. Insurance will not cover clinical trials, but, in the United States, after ONCONASE for mesothelioma passes test phases and reaches the market, it will be partially covered by insurance.
Get ONCONASE treatment for mesothelioma
Contact asbestosis and mesothelioma centers and ask about ONCONASE if you happen to have any further questions regarding mesothelioma treatment or recovery from ONCONASE treatment cycle. It is important to know everything about a new drug before giving it a try, so contact because it is absolutely free.